Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 10/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3717604 | 0.90 | TSHR (0.38) | TSHRALDH1A1HPGD | |
| SCHEMBL36451 | 0.87 | TSHR (0.53) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| SCHEMBL23964584 | 0.87 | TSHR (0.53) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| SCHEMBL473649 | 0.85 | TSHR (0.55) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| SCHEMBL2035080 | 0.83 | TSHR (0.52) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| Acrylic Acid SCHEMBL28639653 | 0.83 | TSHR (0.49) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| SCHEMBL17947569 | 0.81 | TSHR (0.47) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| SCHEMBL94906 | 0.81 | TSHR (0.68) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| SCHEMBL13893065 | 0.80 | TSHR (0.53) | TSHRTHRBALDH1A1HPGDCYP3A4 | |
| SCHEMBL5606160 | 0.79 | TSHR (0.49) | TSHRTHRBALDH1A1HPGDCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1604231-B9 | PHOTOCHROMIC OCULAR DEVICES | TRANSITIONS OPTICAL INC (US) | 2009-01-07 | — | — | EP | claimed |
| EP-1604231-B1 | PHOTOCHROMIC OCULAR DEVICES | TRANSITIONS OPTICAL INC (US) | 2008-07-02 | — | — | EP | claimed |
| US-12606660-B2 | Acrylic rubber composition | NOK CORPORATION (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20240228718-A9 | DECORATIVE SHEET | C.I. TAKIRON CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| CN-115023464-B | Acrylic rubber composition | NOK株式会社 | 2024-06-11 | — | — | CN | disclosed |
| US-20240158548-A1 | ETHYLENE-(METH)ACRYLATE-BASED ELASTOMER AND METHOD FOR PRODUCING THE SAME | UNIMATEC CO., LTD. (JP) | 2024-05-16 | — | — | US | disclosed |
| US-20240132686-A1 | DECORATIVE SHEET | CI TAKIRON CORP (JP) | 2024-04-25 | — | — | US | disclosed |
| US-11932644-B2 | Carbamate ester compound and acrylic rubber composition containing the same | UNIMATEC CO., LTD. (JP) | 2024-03-19 | — | — | US | disclosed |
| CN-117642438-A | Fluorine-containing copolymer and surface-modified substrate using same | 优迈特株式会社 | 2024-03-01 | — | — | CN | disclosed |
| EP-4310109-A1 | ETHYLENE-(METH)ACRYLATE ELASTOMER AND MANUFACTURING METHOD THEREFOR | Unimatec Co., Ltd. (JP) | 2024-01-24 | — | — | EP | disclosed |
| EP-4310111-A1 | ETHYLENE/(METH)ACRYLATE-BASED ELASTOMER AND PRODUCTION METHOD THEREFOR | Unimatec Co., Ltd. (JP) | 2024-01-24 | — | — | EP | disclosed |
| EP-1243606-A1 | A resin composition for forming a matte-finished surface and a method of forming a matte-finished surface | Four Trend, Inc. (US) | 2002-09-25 | — | — | EP | disclosed |
| EP-1231190-A1 | Coated optical fiber | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-08-14 | — | — | EP | disclosed |
| US-6395393-B1 | MULTILAYER; CORE WITH PHOTOCURABLE COVERINGS | THE FURUKAWA ELECTRIC CO., LTD. (JP) | 2002-05-28 | — | — | US | disclosed |
| US-20020028287-A1 | Manufacture of optical fiber and optical fiber tape | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-03-07 | — | — | US | disclosed |
| EP-1182178-A1 | Manufacture of optical fiber and optical fiber tape | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2002-02-27 | — | — | EP | disclosed |
| US-6198867-B1 | POLYSILOXANE ENDCAPPED WITH (METH)ACRYL GROUP, AND CONTAINING AROMATIC HYDROCARBON GROUPS ATTACHED TO SILICON ATOMS, AN UNSATURATED COMPOUND, AND A PHOTOPOLYMERIZATION CATALYST; LOW VISCOSITY, CURES TO A LOW YOUNG'S MODULUS COATING | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| US-6174604-B1 | BINDER COMPRISING A RADICAL POLYMERIZABLE OLIGOMER, A RADICAL POLYMERIZABLE MONOMER, A PHOTOPOLYMERIZATION INITIATOR, AND A SILICONE COMPOUND MODIFIED WITH A GROUP CONTAINING A LONG CHAIN ETHYLENE OXIDE-PROPYLENE OXIDE; SUBMARINE CABLES | THE FURUKAWA ELECTRIC CO., LTD. (JP) | 2001-01-16 | — | — | US | disclosed |
| EP-1046619-A2 | Coated optical fibres and their manufacture | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-10-25 | — | — | EP | disclosed |
| EP-0970978-A1 | Radiation-curable liquid resin composition suitable for coating optical fibers and optical fiber coated therewith | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2000-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11932644-B2 | Carbamate ester compound and acrylic rubber composition containing the same | SUV39H1, NCEH1, SUV39H2 | TSHR 3093/4885THRB 3153/4885ALDH1A1 3226/4885 |
| US-12606660-B2 | Acrylic rubber composition | SMURF2, SMURF1, RPLP0 | TSHR 4628/4885THRB 2897/4885ALDH1A1 3794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.